Eliezer Giladi Selected Research

davunetide

8/2013	NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport.
1/2011	Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
7/2010	NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eliezer Giladi Research Topics

Disease

5	Tauopathies 01/2022 - 05/2009
4	Schizophrenia (Dementia Praecox) 01/2019 - 07/2010
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 09/2003
2	Autistic Disorder (Autism) 08/2022 - 01/2019
2	Inflammation (Inflammations) 01/2021 - 03/2003
2	Cognitive Dysfunction 10/2020 - 11/2015
2	Frontotemporal Dementia (Semantic Dementia) 01/2014 - 01/2014
1	Infections 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Bone Resorption 01/2021
1	Osteolysis 01/2021
1	Muscular Diseases (Myopathy) 10/2020
1	Ileitis 06/2018
1	Colitis 01/2018
1	Mental Disorders (Mental Disorder) 11/2015
1	Disease Progression 08/2013
1	Craniocerebral Trauma (Head Injury) 03/2003

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 08/2022 - 01/2011
5	Peptides (Polypeptides)IBA 01/2019 - 03/2003
3	Pharmaceutical PreparationsIBA 01/2021 - 05/2009
3	Messenger RNA (mRNA)IBA 01/2021 - 03/2003
3	davunetideIBA 08/2013 - 07/2010
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022 - 01/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2018
2	Amyloid beta-PeptidesIBA 01/2011 - 09/2003
1	Carrier Proteins (Binding Protein)IBA 11/2021
1	TitaniumIBA 01/2021
1	NorleucineIBA 01/2021
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	InterferonsIBA 06/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Dextran SulfateIBA 01/2018
1	Risperidone (Risperdal Consta)FDA LinkGeneric 11/2015
1	Beclin-1IBA 01/2014
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2014
1	Amyloid (Amyloid Fibrils)IBA 01/2014
1	Antipsychotic Agents (Antipsychotics)IBA 07/2010
1	Clozapine (Clozaril)FDA LinkGeneric 07/2010
1	Neuroprotective AgentsIBA 03/2003

Therapy/Procedure

1	Therapeutics 10/2020
1	Intranasal Administration 01/2019
1	Injections 03/2003